Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First in Man Study to Evaluate Initial Safety”

779 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 779 results

Early research (Phase 1)Study completedNCT05925920
What this trial is testing

Study of Subcutaneously Administered ENT-03 for the Treatment of Obesity and Diabetes

Who this might be right for
ObesityDiabetes Mellitus, Type 2
Metabolics Pharma 49
Post-approval studies (Phase 4)Not Yet RecruitingNCT07624669
What this trial is testing

A First in Human Study Investigating the Safety of an Unloaded and Loaded (With a Tetanus-containing Vaccine Booster) Microneedle Patch in Healthy Adults

Who this might be right for
Vaccine DeliveryTetanus
Microneedle Solutions Ltd 30
Not applicableStudy completedNCT06203262
What this trial is testing

Ventricular Catheter Ablation Study (VCAS)

Who this might be right for
Ventricular TachyarrhythmiaVentricular ArrythmiaPVC - Premature Ventricular Complex+2 more
Field Medical 34
Early research (Phase 1)Not Yet RecruitingNCT07646353
What this trial is testing

First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy Adults

Who this might be right for
Malaria, Falciparum
GlaxoSmithKline 40
Early research (Phase 1)Study completedNCT04144842
What this trial is testing

Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017

Who this might be right for
Solid TumorNeoplasms
Alligator Bioscience AB 27
Early research (Phase 1)Study completedNCT03518554
What this trial is testing

A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung CancerHead and Neck CancerEsophageal Cancer+1 more
Jacobio Pharmaceuticals Co., Ltd. 38
Not applicableLooking for participantsNCT05809856
What this trial is testing

Feasibility Study to Evaluate the Safety of the Autologous GrOwnValve Transcatheter Pulmonary Heart Valve

Who this might be right for
Pulmonary Valve Insufficiency
Charite University, Berlin, Germany 7
Early research (Phase 1)Study completedNCT05890105
What this trial is testing

Learn About the Study Medicine PF-07853578 and How it Acts in the Bodies of Healthy Adults

Who this might be right for
Healthy Participants
Pfizer 23
Early research (Phase 1)Study completedNCT06780254
What this trial is testing

Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Single- and Multiple-Ascending Doses of MH-001 in Healthy Volunteers

Who this might be right for
Healthy
Vespina Lifesciences Inc. 58
Testing effectiveness (Phase 2)Ended earlyNCT03866187
What this trial is testing

Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection

Who this might be right for
Hepatitis B, Chronic
GlaxoSmithKline 236
Early research (Phase 1)Study completedNCT05581407
What this trial is testing

Safety, Tolerability, and Immunogenicity of TETRALITE, a Novel Adjuvanted, Low-dose Influenza Vaccin

Who this might be right for
Influenza
LiteVax BV 60
Early research (Phase 1)Looking for participantsNCT05318534
What this trial is testing

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease

Who this might be right for
First in Man Study to Evaluate Initial Safety
Gliknik Inc. 70
Early research (Phase 1)Study completedNCT00887406
What this trial is testing

Study of GSK961081 in Healthy Volunteer Subjects

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Theravance Biopharma 46
Testing effectiveness (Phase 2)Looking for participantsNCT06914128
What this trial is testing

PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Who this might be right for
MTAP-deleted Solid Tumors
Bayer 450
Early research (Phase 1)Study completedNCT06673667
What this trial is testing

First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants

Who this might be right for
Healthy Participants Study
Kymera Therapeutics, Inc. 118
Early research (Phase 1)WithdrawnNCT05487495
What this trial is testing

Donor-Derived CD5 CAR T (CT125B) Cells for Relapsed or Refractory T- Cell Acute Lymphoblastic Leukemia/Lymphoma

Who this might be right for
T-Cell Acute Lymphoblastic Leukemia/Lymphoma
Beijing Boren Hospital
Early research (Phase 1)Looking for participantsNCT06258408
What this trial is testing

BB102 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Broadenbio Ltd., Co. 78
Testing effectiveness (Phase 2)Looking for participantsNCT06877650
What this trial is testing

First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Shanghai JMT-Bio Inc. 436
Early research (Phase 1)Study completedNCT07063823
What this trial is testing

A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

Who this might be right for
Celiac DiseaseHealthy
Nielsen Fernandez-Becker 18
Very early researchStudy completedNCT06565208
What this trial is testing

First in Human SAD/MAD Safety and PK Study With Adult DMD Safety and PK Cohort

Who this might be right for
Duchenne Muscular Dystrophy
Satellos Bioscience, Inc. 77
Load More Results